Pharmaceuticals, Biotechnology and Life Sciences
Genentech has received FDA’s approval of Xofluza, which is the first and only antiviral medicine indicated specifically for patients at…
Acerus Pharmaceuticals said Thursday in a press release that new data showed that Natesto increases serum testosterone and improves symptoms…
GENEVA & NEWARK, Calif.–(BUSINESS WIRE)–Selexis SA and Teneobio, Inc. announced today that they have signed three commercial license agreements (CLAs)…
NeuClone starts dosing NeuLara ustekinumab the first patients, a Johnson and Johnson’s Stelara biosimilar candidate, in a Phase I clinical…
Cadent Therapeutics has named Dawn Wilson appointed as Vice President, Clinical Operations, as it releases the data from Phase 2…
Inversago has welcomed Dennis Kim, MD, MBA and Tara Nickerson, PhD, MBA as new independent directors, following its goal to…
MELBOURNE, Australia–(BUSINESS WIRE)–Neuren Pharmaceuticals (ASX: NEU) today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug…
San Diego based Plexium on Thursday launched the company with $28 Million in series A financing, aimed for advance its DELPhe platform to discover novel E3 ligase-modulating therapeutics to treat cancer and neurodegenerative diseases.
Out of 105 patients were enrolled and treated in Sensorion’s SENS-111 Phase 2 trial, the last patient’s last visit of…